Transcriptomic analysis provides insight into the mechanism of IKKβ-mediated suppression of HPV18E6-induced cellular

Quincy P Collins1, Michael J Grunsted1, Dahiana Arcila1,2

  • 1Department of Biology, University of Oklahoma, Norman, OK 73019, USA.

G3 (Bethesda, Md.)
|February 1, 2023
PubMed

Insights

Researchers identified key genes and pathways, including Hippo and Toll, involved in suppressing human papillomavirus (HPV)-induced cervical cancer defects. This discovery offers potential new drug targets for HPV-associated cancers.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • High-risk human papillomaviruses (HPVs) 16 and 18 cause over 70% of cervical cancers and other HPV-associated malignancies.
  • Current treatments for HPV-associated cancers have limited efficacy, necessitating novel molecularly-targeted therapeutics.
  • Understanding HPV disease mechanisms is crucial for developing new treatments.

Purpose of the Study:

  • To identify genes and pathways involved in the suppression of HPV18E6 oncoprotein-induced cellular abnormalities.
  • To investigate the role of IKKβ in mediating the suppression of E6-induced defects.
  • To explore potential novel therapeutic targets for HPV-associated cancers.

Main Methods:

  • Utilized a Drosophila model of HPV18E6 and human E3 ubiquitin ligase (hUBE3A).
  • Performed transcriptomic analysis to identify differentially expressed genes upon reduced IKKβ levels.
  • Conducted functional genetic interaction screens (RNAi, overexpression, mutant strains) and RT-PCR validation.

Main Results:

  • Transcriptome analysis identified 215 differentially expressed genes, with 151 annotated.
  • Genetic screens revealed involvement of Hippo and Toll pathways, and junctional complexes in modulating E6-induced defects.
  • Confirmed the role of Hippo and Toll pathways in IKKβ-mediated suppression of E6 + hUBE3A-induced abnormalities.

Conclusions:

  • The study elucidates the molecular mechanisms underlying HPV-induced cancer, highlighting the involvement of Hippo and Toll pathways.
  • Identified IKKβ as a key regulator in suppressing HPV-induced cellular abnormalities.
  • Provides a foundation for developing novel drug targets for HPV-associated cancers.